Eli Lilly & Co. and Abbott Laboratories are offering help to the 13.8 million American men who have low levels of testosterone. Doctors warn demand for the treatments could lead to overuse with deadly side effects. Bloomberg's Shannon Pettypiece reports. (Source: Bloomberg)

Running Time: 01:56